Steven G Carmella Selected Research

Nitrosamines

9/2017	High Level of Tobacco Carcinogen-Derived DNA Damage in Oral Cells Is an Independent Predictor of Oral/Head and Neck Cancer Risk in Smokers.
1/2016	Exposure and Metabolic Activation Biomarkers of Carcinogenic Tobacco-Specific Nitrosamines.
8/2013	High throughput liquid and gas chromatography-tandem mass spectrometry assays for tobacco-specific nitrosamine and polycyclic aromatic hydrocarbon metabolites associated with lung cancer in smokers.
1/2013	Tobacco-specific nitrosamine exposures in smokers and nonsmokers exposed to cigarette or waterpipe tobacco smoke.
4/2009	Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers.
11/2008	Smokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specific nitrosamine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven G Carmella Research Topics

Disease

31	Lung Neoplasms (Lung Cancer) 01/2020 - 04/2002
30	Neoplasms (Cancer) 01/2022 - 05/2002
10	Carcinogenesis 01/2022 - 06/2004
6	Inflammation (Inflammations) 10/2019 - 06/2014
3	Head and Neck Neoplasms (Head and Neck Cancer) 09/2017 - 08/2013
3	Squamous Cell Carcinoma of Head and Neck 09/2017 - 08/2013
2	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 01/2012
2	Esophageal Neoplasms (Esophageal Cancer) 01/2016 - 06/2014
2	Tobacco Use Disorder (Nicotine Dependence) 02/2010 - 11/2008
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 09/2017
1	Leukemia 12/2014
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2014
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2011
1	Ovarian Neoplasms (Ovarian Cancer) 01/2009
1	Heart Diseases (Heart Disease) 03/2008
1	Insulin Resistance 09/2006
1	Hyperglycemia 09/2006
1	Neuromuscular Diseases (Neuromuscular Disease) 03/2006
1	Lung Diseases (Lung Disease) 12/2005
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2003
1	Brain Neoplasms (Brain Tumor) 04/2002

Drug/Important Bio-Agent (IBA)

27	Biomarkers (Surrogate Marker)IBA 10/2019 - 12/2005
26	CarcinogensIBA 01/2022 - 04/2002
17	SmokeIBA 01/2018 - 11/2002
16	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 03/2020 - 12/2003
9	CotinineIBA 01/2018 - 03/2008
9	Nicotine FDA Link 09/2017 - 03/2008
8	4- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA 03/2016 - 04/2002
6	DNA AdductsIBA 01/2022 - 11/2002
6	NitrosaminesIBA 09/2017 - 11/2008
6	phenanthreneIBA 01/2016 - 12/2004
5	Benzene (Benzole)IBA 01/2022 - 05/2010
5	AcidsIBA 01/2019 - 07/2008
5	4- (methylnitrosamino)- 1- (3- pyridyl)- 1- butan- 1- olIBA 03/2016 - 03/2008
5	GlucuronidesIBA 08/2015 - 03/2008
4	Dinoprostone (PGE2)FDA Link 01/2019 - 07/2016
4	N'-nitrosonornicotine (nitrosonornicotine)IBA 01/2016 - 05/2002
4	nitrosobenzylmethylamineIBA 01/2016 - 08/2006
4	Acrolein (Aqualin)IBA 01/2015 - 07/2007
3	7- hydroxy- 5,11- dioxotetranorprostane- 1,16- dioic acidIBA 01/2019 - 01/2019
3	Anthocyanins (Anthocyanin)IBA 01/2016 - 01/2009
3	1-hydroxypyreneIBA 08/2015 - 03/2008
3	2-butenal (crotonaldehyde)IBA 01/2015 - 05/2010
2	Environmental CarcinogensIBA 01/2022 - 03/2020
2	phenethyl isothiocyanate (PEITC)IBA 01/2022 - 07/2016
2	F2-Isoprostanes (F2 Isoprostanes)IBA 01/2019 - 03/2008
2	EicosanoidsIBA 01/2019 - 01/2019
2	N 30IBA 09/2017 - 12/2003
2	IsothiocyanatesIBA 07/2016 - 06/2004
2	protocatechuic acidIBA 01/2016 - 06/2014
2	CytokinesIBA 01/2016 - 06/2014
2	EnzymesIBA 12/2013 - 04/2005
2	Indicators and Reagents (Reagents)IBA 09/2012 - 07/2008
2	AflatoxinsIBA 01/2012 - 04/2005
2	r- 1,t- 2,3,c- 4- tetrahydroxy- 1,2,3,4- tetrahydrophenanthreneIBA 11/2011 - 01/2009
2	Epoxy Compounds (Epoxides)IBA 07/2011 - 05/2010
2	Hemoglobins (Hemoglobin)IBA 11/2002 - 04/2002
1	quinone (benzoquinone)IBA 11/2020
1	trans-1,2-dihydro-1,2-naphthalenediolIBA 03/2020
1	Free RadicalsIBA 01/2018
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 05/2016
1	7,8-dihydromethysticinIBA 03/2016
1	phenanthrene tetraolIBA 01/2016
1	InterleukinsIBA 06/2014
1	hydroxide ionIBA 02/2014
1	Volatile Organic CompoundsIBA 02/2014
1	GlucosinolatesIBA 02/2014
1	Methoxsalen (Oxsoralen)FDA Link 12/2013
1	5-MethoxypsoralenIBA 12/2013
1	3,3'-diindolylmethane (diindolylmethane)IBA 12/2013
1	Ethylene Oxide (Oxirane)IBA 04/2012
1	Acetylcysteine (Siran)FDA LinkGeneric 04/2012
1	1,3-butadiene (divinyl)IBA 04/2012
1	nitrosamine 4- (methylnitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA 03/2012
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2012
1	ORALIT (ORS)IBA 11/2011
1	Benzo(a)pyreneIBA 05/2010
1	OilsIBA 05/2010
1	Formaldehyde (Formol)FDA Link 09/2009
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 11/2008
1	Hydroxy AcidsIBA 07/2008
1	pyridineIBA 07/2008
1	Carbon MonoxideIBA 03/2008
1	Fibrinogen (Factor I)FDA Link 03/2008
1	C-Reactive ProteinIBA 03/2008
1	Tobacco Smoke Pollution (Passive Smoking)IBA 08/2007
1	Glucose (Dextrose)FDA LinkGeneric 09/2006
1	Insulin (Novolin)FDA Link 09/2006
1	CreatineIBA 03/2006
1	oltiprazIBA 04/2005
1	indole-3-carbinolIBA 06/2004
1	CokeIBA 12/2003
1	CreatinineIBA 12/2003
1	Ointments (Pastes)IBA 12/2003

Therapy/Procedure

1	Chemoprevention 06/2014
1	Tobacco Use Cessation Devices 02/2010